| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |